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Abstract
Background: The aim of this study was to investigate the potential significance of the central macular thickness
(foveal thickness-FT) and choroidal thickness (CT) in the eyes of patients with iron-deficiency anemia, the most
common form of the anemia, via enhanced-depth imaging optical coherence tomography (EDI-OCT). We also
investigated whether such changes might serve as an early indicator of underlying hematological disease.
Methods: This prospective clinical study compared 96 female patients with iron-deficiency anemia and 60 healthy
female control subjects. The macular and choroidal thicknesses in the temporal and nasal subfoveal areas were
measured using enhanced-depth imaging optical coherence tomography (EDI-OCT) at 500 and 1500 microns and
in five different regions (FCT, T1500, T500, N500, and N1500).
Results: The mean ages of the patients and healthy controls were 34.08 ± 10.39 years and 32.29 ± 8.28 years,
respectively (P =0.232). There were no significant changes in macular thickness between the groups (225.58 ± 19.76
vs. 222.45 ± 13.51, P =0.2). The choroidal thickness was significantly reduced in the patient group relative to the
controls at all measured points (foveal choroidal thickness, P = 0.042; nasal–500 microns, P = 0.033; temporal–500
microns, P = 0.033; and temporal–1500 microns, P = 0.019). At some points, the choroidal thickness findings
correlated with the hemoglobin values (temporal–500 microns, r = −0.287, P = 0.001; nasal–500 microns, r = −0.287,
P = 0.005; nasal–1500 microns, r = −0.245, P = 0.016; and temporal–1500 microns, r = −0.280, P = 0.06).
Conclusions: Patients with iron-deficiency anemia had a significantly reduced choroidal thickness.
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Background
The development of optical coherence tomography
(OCT) technology has revolutionized the diagnostic,
monitoring, and therapeutic approaches to many retinal
and systemic diseases. Spectral domain OCT offers
improved axial resolution (3 μm), reduces examination
times, and accordingly reduces both patient exposure
and artifacts by allowing 19,000 A-scans per second. The
latest development in OCT technology, swept-source
longer wavelength OCT, better penetrates the retinal
pigment epithelium (RPE) and thus allows better
visualization of the choroid; however, its use is currently
limited to research purposes.
Similar to swept-source OCT, enhanced-depth imaging
(EDI), which was recently introduced by Spaide et al. [1],
provides greater penetration through the RPE and allows
accurate in vivo deep choroidal imaging and measure-
ment [2]. Changes in choroidal thickness (CT) have been
found to correlate with several factors and systemic
conditions such as smoking, changes in arterial pressure,
hemodialysis, obstructive sleep apnea syndrome, and
systemic sclerosis [3–7].
According to the World Health Organization (WHO),
the overall global prevalence of iron-deficiency anemia is
25 %, with rates of 12.7 %, 30.2 %, and 41.8 % among
adult men, women of reproductive age, and pregnant
women, respectively [8]. Infants have the highest
* Correspondence: erhanyumusak@yahoo.com
1Department of Ophthalmology, Kırıkkale University School of Medicine,
Kırıkkale, Turkey
5Kirikkale University Medical Faculty Hospital District Tahsin Duru Akdeniz
Caddesi No: 14, Yahsihan/Kırıkkale 71450, Turkey
Full list of author information is available at the end of the article
© 2015 Yumusak et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Yumusak et al. BMC Ophthalmology  (2015) 15:186 
DOI 10.1186/s12886-015-0163-3
prevalence of iron-deficiency anemia, followed by
pregnant women and women of reproductive age. In
women of reproductive age, the risk of iron-deficiency
anemia may accompany a range of important causes of
morbidity and mortality [9, 10]. These conditions are
the most important cause of menorrhagia in patients
with iron-deficiency anemia [11, 12].
In this study, we investigated the potential significance
of macular thickness and CT in the eyes of patients with
iron-deficiency anemia, the most common form of
anemia. We also considered the possibility that such
changes might serve as an early indicator of underlying
hematological disease. Using semi-automated choroidal
segmentation software, we measured changes in CT in the
eyes of women of reproductive age with iron-deficiency
anemia in comparison with a control group.
Methods
This prospective clinical study was conducted between
2014 and 2015 in accordance with the tenets of the
Declaration of Helsinki. The trial protocol was ap-
proved by the Local Ethical Committee of the Kırıkkale
University. Trial registration was requested on October
12, 2015 (decision no:01/04). All patients and control
subjects voluntarily participated in the study and signed
an informed consent form prepared according to the
ethical protocol.
The patient group consisted of patients with a diagno-
sis of iron-deficiency anemia who were followed by the
Hematology Clinic, whereas the control group consisted
of healthy adult women of reproductive age. This study
included only adult women of reproductive age to
avoid the effects of gender, age, and hormonal status.
The exclusion criteria were a previously diagnosed
systemic or chronic disease or condition (e.g., hyperten-
sion, smoking, ocular surgery) in one or both eyes, an
axial length >24 ± 1.0 mm, and a refractive measurement
exceeding 2.0 diopters.
Patients with a previous diagnosis of iron-deficiency
anemia were selected randomly for inclusion in the
patient group. The study included 96 eyes from 96
patients followed in this manner, and only the patients
right eyes were evaluated to avoid intra-individual bias.
In the control group, 60 eyes from 60 patients were also
evaluated and fully assessed. Each patient was subjected
individually to visual acuity, slit-lamp biomicroscopy,
intraocular pressure, and fundus examinations.
CT and macular thickness measurement was performed
on an EDI-OCT scanning system (OCT Advance Nidek
RS-3000; Nidek Co. Ltd., Gamagori, Japan). In all patients,
the central macular thickness (FT) was measured in the
right eye prior to evaluation. Patients subsequently under-
went EDI-OCT scanning. Technicians then manually
drew the choroid and sclera boundaries with assistance
from software programs (Fig. 1). These boundaries limited
the Bruch membrane between the subfoveal points (FCT)
to 500 or 1500 microns in the nasal (N500, N1500) and 500
or 1500 microns in the temporal regions (T500, T1500) for
CT measurements (Fig. 2). Choroid and sclera demar-
cation was performed independently by two experi-
enced technicians. The averages of the obtained
values were used.
SSPS statistical software (SPSS for Windows, version
22.0; SPSS, Inc., Chicago, IL, USA) was used for the statis-
tical analysis. The results of the descriptive analysis are
presented as numbers, percentages, means, medians, and
standard deviations. The paired t test and chi-square test
were used to compare variables between the patient and
control groups, and Pearson’s correlation coefficient
was used to evaluate correlations. A multiple linear
regression analysis (forward) was used to determine
confounding factors among the variables. A P value < 0.05
was considered statistically significant.
Results
The anemia group consisted of 96 female patients of repro-
ductive age. The mean age was 34.08 ± 10.39 years (range:
18–49 years). The control group included 60 patients with
a mean age of 32.2 9 ± 8.28 years (range: 17–49 years). The
groups did not differ significantly with respect to age
(P =0.232). Patients with anemia had a mean hemoglobin
level of 9.59 ± 1.18 (range: 6.90–11). The mean duration
of anemia was 4.18 ± 3.51 years (range: 1–15 years).
Forty-nine patients with a mean age of 33.86 ± 10.21 years
were in the follicular phase of the menstrual cycle. Forty-six
patients with a mean age of 34.32 ± 10.68 years were in the
luteal phase. There were no significant differences between
the patients in each phase with respect to age,
hemoglobin level (10.09 ± 1.32 vs. 10.687 ± 1.55), and
CT (P = 0.8, P = 0.7, and P > 0.05, respectively; (Table 1).
No statistically significant difference was observed
between the groups with respect to FT (P > 0.05). When
all measured CT points were compared, the anemia
group had significantly lower values than the control
group (Table 2).
Fig. 1 Choroid boundaries were manually drawn by a technician
with software assistance
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In the patient group, no significant association was
observed between the duration of anemia and the CT
(P > 0.05). However, significant correlations were ob-
served between some CT points and the hemoglobin
values (temporal–500 micron, r = −0.287, P = 0.001;
nasal–500 microns, r = −0.287, P = 0.005; nasal–1500
microns, r = −0.245, P = 0.016; temporal–1500 mi-
crons, r = −0.280, P = 0.06). Moreover, a statistically
significant negative correlation was observed between
age and CT (P <0.05).
We next assessed the independent effects of age and
hemoglobin level on changes in CT through a multiple
linear regression analysis. Only age independently
affected the FCT (p = 0.004), whereas both age and the
hemoglobin independently affected the N500, N1500,
T500, and T1500 values. In other words, no overlap was
observed between these factors; each CT point was
affected independently by the hemoglobin level and
age, with no potential confounding effect (P <0.05 for
all; Table 3).
Discussion
The choroid covers the outer retina and is among
the most vascularized tissues in the body. This tissue
supplies oxygen and nutrition to and provides
temperature regulation for the retina. With respect
to the retina, the choroid assumes the important
roles of growth factor secretion and removal of
retinal residues [13]. Both the structure and function
of the choroidal tissue are essential factors ensuring
a normal and functional retina. An abnormal chor-
oidal blood volume, impaired photoreceptor func-
tion, and/or even a loss of blood flow can lead to
injury [14]. The choroid features both sympathetic
and parasympathetic innervation to regulate the
choroidal blood flow, which is controlled by an auto-
regulatory mechanism [15].
The CT may be affected by age, axial length, and
refractive errors [16, 17]. Diurnal changes in CT have
also been reported [18]. The choroid is affected by
changes in blood pressure and intraocular pressure
through an autoregulatory mechanism [19]. Because
the choroid features a rich vascular structure, these
changes greatly affect the autoregulation of CT [20]. For
example, Tanabe et al. demonstrated a significant relation-
ship between the choroidal vessel diameter and CT [21].
Similarly, Vance et al. found that phoshodiesterase-5
inhibitors such as sildenafil citrate, which promotes
smooth muscle relaxation, can lead to an increased
CT [22].
In the current study, we found observed a significant
reduction in CT in the patient group. In a review of the
literature on this subject, we did not identify any previ-
ous research that would allow a direct comparison.
Karaca et al. collected choroidal measurements at three
points in their study of patients with obstructive sleep
apnea syndrome and found no significant differences
relative to control group measurements [6]. Pekel et al.
evaluated choroidal changes in patients who had under-
gone cardiopulmonary bypass and also failed to detect any
significant changes [4]. In addition, Ngo et al. presented a
case report of high altitude-induced retinopathy in a
patient with significantly increased CT [23].
Hematological diseases affect millions of patients world-
wide and are a significant cause of both morbidity and
mortality. Anemia consists of a group of hematologic
disorders characterized by a decrease in the number of
red blood cells and/or hemoglobin level. Factors such as
hypoxia, venous stasis, vasospasm, and increased vascular
permeability have been proposed in the pathogenesis of
anemic retinopathy [24–26].
Fig. 2 The choroidal thickness was measured manually with
software assistance
Table 1 Comparison of patients in two different phases of menstrual cycle (t-test) (LP = Luteal Phase, FP = Follicular phase; std.dev:
standart deviation; FCT: choroidal thickness at fovea; N500, choroidal thickness at 500 μm nasal to the fovea; N1500, choroidal
thickness at 1500 μm nasal to the fovea; T500, choroidal thickness at 500 μm temporal to the fovea; T1500, choroidal thickness at
1500 μm temporal to the fovea; FT: central macular thickness)
N Age Hbvalue FT FCT N500 N1500 T500 T1500
Mean FP 49 33.86 10.09 224.55 335.06 325.10 319.33 327.80 304.39
LP 47 34.32 10.34 226.66 324.47 318.51 315.04 310.47 288.06
Std. Dev. FP 10.21 1.33 19.23 63.42 81.71 81.71 88.59 92.29
LP 10.68 1.35 20.45 59.47 81.90 78.75 82.39 77.14
P 0.249 0.001 (with control groups) 0253 0.581 0.433 0.643 0.700 0.554
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Therefore, we hypothesize that because the choroid
is the most vascular area of the eye, the above factors
also affect choroidal tissues in patients with iron-
deficiency anemia.
In our study, we observed a significant correlation
between hemoglobin levels and CT. Moreover, we
observed an inverse correlation between age and CT.
Ding et al. reported similar results with respect to CT in a
study of areas outside the subfoveal wet area in subjects
younger than 60 years of age but failed to detect a
correlation between age and subfoveal CT [27].
In the Beijing Eye Study, 3468 individuals were exam-
ined longitudinally, and several parameters related to the
subfoveal CT was assessed [28]. That study observed
direct links between age or the degree of myopia and
CT. However, the potential associations or lack thereof
between blood pressure, ocular perfusion, smoking, and
alcohol consumption with diabetes mellitus and arterial
hypertension remain controversial. However, that study
relied only on single-point measurements. Notably,
choroidal volume measurements risk being subject to
false information [29].
In our study, we did not observe any significant
differences between the two menstrual cycle phases.
Because the menstrual cycle has a short duration, it
is possible that we were unable observe a hormonal
effect, or that the hormonal status does not affect
CT. We did observe significant but moderate or
weak correlations between the hemoglobin levels and
the CT values at some measured points. However,
the previously observed inverse correlation between
age and CT might have affected this correlation [27].
The patients ranged in age from 17 to 49 years. No
significant difference was observed between the
duration of anemia duration and CT. This suggests
that changes in CT do not progress during the
course of anemia.
Conclusion
Increasing attention is being paid to information about
the choroidal structure and function. We think that as
future studies of patients with anemia reveal the
possible effects of this condition on choroidal tissue,
the observation of decreased CT at all measured points
in patients with iron-deficiency anemia might suggest
the inclusion of this value as a clinical measurement in
this patient population.
Table 2 The numbers, mean, median ages, minimum, maximum values and choroidal thickness measurements of the study and
control groups at baseline. FCT, choroidal thickness at fovea; N500, choroidal thickness at 500 μm nasal to the fovea; N1500,
choroidal thickness at 1500 μm nasal to the fovea; T500, choroidal thickness at 500 μm temporal to the fovea; T1500, choroidal
thickness at 1500 μm temporal to the fovea; FT: central macular thickness. (t-test)
Age Hb value FT FCT N500 N1500 T500 T1500
Anemia N 96 96 96 96 96 96 96 96
Mean 34.08 10.21 225.58 329.88 321.88 317.23 319.31 296.40
Median 34.50 10.65 220.00 326.50 315.00 319.00 321.00 294.00
Std. Deviation 10.396 1.342 19.760 61.431 81,445 79.810 85.607 85.168
Minimum 18 7 199 201 121 109 88 79
Maximum 49 12 291 481 567 575 537 500
Control N 60 60 60 60 60 60 60 60
Mean 32.29 14.42 222.45 349.94 347.39 333.74 346.45 326.58
Median 34.00 14.00 219.00 352.00 344.00 323.00 352.00 315.00
Std. Deviation 8.283 0.95 13.513 59.064 56.718 55.549 63.100 66.157
Minimum 17 13 200 217 247 231 231 205
Maximum 49 16 256 442 508 458 525 474
P 0.254 0.000 0.276 0.043 0.032 0.157 0.033 0.019
Table 3 Multiple linear regression analysis between choroidal
thickness, age and hemoglobine values
Beta(β) P
N500 Hb −0.290 0.003
Age −0.269 0.006
N1500 Hb −0.249 0.009
Age −0.364 0.000
T500 Hb −0.342 0.000
Age −0.289 0.002
T1500 Hb −0.283 0.003
age −0.319 0.001
FCT Hb - -
Age −0.291 0.004
FCT choroidal thickness at fovea; N500 choroidal thickness at 500 μm nasal to
the fovea; N1500 choroidal thickness at 1500 μm nasal to the fovea; T500
choroidal thickness at 500 μm temporal to the fovea; T1500 choroidal thickness
at 1500 μm temporal to the fovea; Hb Hemoglobin
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